Dr. Kirsten Grüneberg, Co-Founder of Grüneberg and Myers, again achieved a place on the IAM Strategy 300 list for 2021.

The IAM Strategy 300 list provides an elite roster of individuals “who are leading the way in the development and implementation of strategies that maximise the value of IP portfolios.” In making selections for this list, IAM looks only to individuals nominated by at least three people outside of their own organizations. The selection process then vets nominees through discussions with senior corporate IP managers across the globe. This process eliminates most nominees, leaving “only those individuals who possess exceptional skill sets – as well as profound insights into the development, creation and management of IP value.”

In listing Dr. Grüneberg on this highly exclusive ranking, IAM stated that she “does outstanding quality work that surpasses even the highest expectations in terms of excellence and efficiency.” They characterized her legal advice as “strategically savvy but straightforward.”

IAM also listed Dr. Grüneberg in the IAM Strategy 300 last year, and has repeatedly included her in their IAM Patent 1000 list of the world’s leading patent professionals. The Grüneberg and Myers firm as a whole has also appeared repeatedly in the IAM Patent 1000 list.

For more information, please see Dr. Grüneberg’s full profile on the IAM Strategy 300 website.

Launched in September 2017, Grüneberg and Myers PLLC is a 100 percent female- and minority-owned international patent firm. With a broad and sophisticated practice, the firm provides a full range of patent support services, including patent prosecution, counseling, post-grant representation, and M&A due diligence to meet the growing and diverse needs of U.S.-based, European, and Asian companies, entrepreneurs, and inventors.